Author Archive for: CURC
This author has not written his bio yet.
But we are proud to say that CURC contributed 212 entries already.
Entries by CURC
AUA Chicago April 28 – May 1, 2023- Here We Come/0 Comments/in Uncategorized/by CURC
Our very own Neal D. Shore, MD, FACS, CURC Director, CPI (Certified Principal Investigator by the Association of Clinical Research Professionals) and Jennifer Sutton, RN, Certified Clinical Research Coordinator, Director of Nursing and Administration, will be attending AUA (American Urological Association) in Chicago at the end of April. https://www.auanet.org/aua2023 Dr. Shore will also be co-moderating […]
Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303/0 Comments/in Uncategorized/by CURC
Matthew D Galsky, Christopher J Hoimes, Andrea Necchi, Neal Shore, J Alfred Witjes, Gary Steinberg, Jens Bedke, Hiroyuki Nishiyama, Xiao Fang, Ritesh Kataria, Eric Sbar, Xieyang Jia & Arlene Siefker-Radtke Click here to read the Future Medicine article.
Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia/0 Comments/in Uncategorized/by CURC
Bilal Chughtai, Sirikan Rojanasarot, Kurt Neeser, Dmitry Gultyaev, Stacey L. Amorosi, Neal D. Shore Click here to read the article.
Efficacy of Enzalutamide Plus Androgen Deprivation Therapy In Metastatic Hormone-Sensitive Prostate Cancer By Pattern of Metastatic Spread: ARCHES Post Hoc Analyses/0 Comments/in Uncategorized/by CURC
Andrew J. Armstrong, Neal D. Shore, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey Holzbeierlein, Arnauld Villers, Arun Azad, Antonio Alcaraz, Boris Alekseev, Taro Iguchi, Francisco Gomez-Veiga, Brad Rosbrook, Ho-Jin Lee, Gabriel P. Haas, and Arnulf Stenzl Click here to read the article.
Comparison of Germline Mutations In African American And Caucasian Men With Metastatic Prostate Cancer/0 Comments/in Uncategorized/by CURC
Elisa M. Ledet PhD, Earle F. Burgess MD, Alexandra O. Sokolova MD, Ellen B. Jaeger BS, Whitley Hatton MS, Marcus Moses MS, Patrick Miller MPH, Patrick Cotogno MS, Jodi Layton MD, Pedro Barata MD, Brian E. Lewis MD, Mari Nakazawa MD, Jason Zhu MD, Beth Dellinger MS, Sara Elrefai MD, Nellie N. Nafissi MD, Jan […]
Niraparib With Androgen Receptor-Axis-Targeted Therapy In Patients With Metastatic Castration-Resistant Prostate Cancer: Safety And Pharmacokinetic Results From A Phase 1b Study (BEDIVERE)/0 Comments/in Uncategorized/by CURC
Fred Saad, Kim N. Chi, Neal D. Shore, Julie N. Graff, Edwin M. Posadas, Jean-Baptiste Lattouf, Byron M. Espina, Eugene Zhu, Alex Yu, Anasuya Hazra, Marc De Meulder, Rao N. V. S. Mamidi, Branislav Bradic, Peter Francis, Vinny Hayreh & Arash Rezazadeh Kalebasty Click here to read the article.
Combined Advanced Prostate Cancer Treatments- Are They Additive?/0 Comments/in Uncategorized/by CURC
Abhishek Srivastava & Neal D. Shore Click here to read the article with a paid subscription.
Treatment of Nonmetastatic Castration- Resistant Prostate Cancer: Focus On Second-Generation Androgen Receptor Inhibitors/0 Comments/in Uncategorized/by CURC
Fred Saad, Martin Bögemann, Kazuhiro Suzuki & Neal Shore Click here to read more.
Treating The Patient And Not Just The Cancer: Therapeutic Burden In Prostate Cancer/0 Comments/in Uncategorized/by CURC
Daniel E. Spratt, Neal Shore, Oliver Sartor, Dana Rathkopf & Kara Olivier Click here to read more.
Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572
Phone: (843) 839-1679
Fax: (843) 286-0119
- Dr. Shore Presents Practice-Changing Data In Prostate Cancer / EMBARK points to potential new standard of care for high-risk BCR.
- AUA Chicago April 28 – May 1, 2023- Here We Come
- Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303
- Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia